Research location

Huy

Belgium

Published trials38

Site observations39

Linked trials published38

Page1 / 1

Research activity in Huy

Belgium

CureCurrent currently publishes aggregate city-level research activity for this location: 38 trials and 39 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Huy

38 linked trials · page 1 of 1

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular DiseaseNCT07181109 · 2025-09-22 · 1 site observation

Study to Evaluate the Efficacy and Safety of AZD4831 in Participants With Heart Failure With Left Ventricular Ejection Fraction > 40%NCT04986202 · 2021-06-30 · 1 site observation

Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.NCT03619213 · 2018-08-27 · 1 site observation

Study to Investigate CSL112 in Subjects With Acute Coronary SyndromeNCT03473223 · 2018-03-21 · 1 site observation

A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF PatientsNCT03066804 · 2017-08-22 · 1 site observation

Comparison of Pre- and Post-discharge Initiation of LCZ696 Therapy in HFrEF Patients After an Acute Decompensation EventNCT02661217 · 2016-02-12 · 1 site observation

Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection FractionNCT01920711 · 2014-07-18 · 1 site observation

A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes MellitusNCT01991795 · 2014-02-10 · 1 site observation

Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure With Reduced Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-REDUCED)NCT01951625 · 2013-11-29 · 1 site observation

Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)NCT01951638 · 2013-11-06 · 1 site observation

A Study in Participants With Type I Diabetes MellitusNCT01454284 · 2012-01-01 · 1 site observation

Descriptive Study in Patients Treated With Vimovo™, Including Registration of the Physicians' Prescribing PatternsNCT01511926 · 2012-01-01 · 1 site observation

Safety and Efficacy of BI 10773 as add-on to Insulin Regimen in Patients With Type 2 Diabetes MellitusNCT01306214 · 2011-02-01 · 1 site observation

BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).NCT01131676 · 2010-07-01 · 1 site observation

Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02NCT00963417 · 2009-08-03 · 1 site observation

Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart FailureNCT00894387 · 2009-05-01 · 1 site observation

Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart FailureNCT00853658 · 2009-03-01 · 1 site observation

Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DMNCT00736099 · 2008-08-01 · 1 site observation

BI 1356 (Linagliptin) in Combination With Metformin and a Sulphonylurea in Type 2 DiabetesNCT00602472 · 2008-02-01 · 1 site observation

Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal FunctionNCT00568009 · 2007-10-01 · 1 site observation

Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast CancerNCT00630032 · 2007-09-01 · 1 site observation

Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast CancerNCT00553410 · 2007-08-01 · 1 site observation

A Follow-up Programme for Patients Using Symbicort SMART in Normal Clinical PracticeNCT00505388 · 2007-07-01 · 1 site observation

ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063DNCT00490139 · 2007-05-16 · 1 site observation

Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 DiabetesNCT00469586 · 2007-04-26 · 1 site observation

TELMA - Observational Study in Daily Medical Practice of the Effectiveness of Telmisartan for Treatment of Hypertension in Patients With and Without Confirmed Albuminuria in BelgiumNCT00886288 · 2006-09-01 · 2 site observations

RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure TrialNCT00358215 · 2006-06-01 · 1 site observation

To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given TogetherNCT00318461 · 2006-05-01 · 1 site observation

A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure MedicinesNCT00232180 · 2006-03-01 · 1 site observation

A Study to Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast CancerNCT00649090 · 2005-03-01 · 1 site observation

Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate CancerNCT01081873 · 2004-06-01 · 1 site observation

Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast CancerNCT00066703 · 2003-11-03 · 1 site observation

S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast CancerNCT00068601 · 2003-10-01 · 1 site observation

Crestor Versus Placebo in Subjects With Heart FailureNCT00206310 · 2003-09-01 · 1 site observation

Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 DiabetesNCT00604396 · 2003-03-01 · 1 site observation

Treatment for Symptomatic Peripheral Neuropathy in Patients With DiabetesNCT00044395 · 2002-07-01 · 1 site observation

Treatment of Peripheral Neuropathy in Patients With DiabetesNCT00044421 · 2002-07-01 · 1 site observation

Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)NCT00095238 · 2002-06-01 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.